This is a routine tax-withholding sale by an insider following equity vesting. The dollar amount is immaterial relative to market cap. No bearish signal, monitor for any discretionary open-market sales by insiders in the coming weeks.
How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Jun 11 $7.31entry
- T+1 · 5mo ago +0.41%α −0.13% · $7.34
- T+5 · 5mo ago +3.83%α +3.40% · $7.59
- T+20 · 4mo ago +25.99%α +24.10% · $9.21
- T+60 · 2mo ago −14.09%α −18.49% · $6.28
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Charles Divita III, an officer and director of Teladoc Health, filed a Form 144 notice of intent to sell 18,074 shares of common stock, with an approximate market value of $125,461 based on the filing date. The shares were acquired through restricted stock vesting on June 10, 2026, and the sale appears related to tax withholding obligations from equity award settlement. This is a routine insider sale tied to equity compensation, not a discretionary open-market sale.
Key Facts
- Charles Divita III (Officer and Director) filed Form 144 to sell 18,074 shares of TDOC common stock.
- Estimated sale value: approximately $125,461 based on filing date.
- Shares acquired via restricted stock vesting on June 10, 2026.
- Sale is to cover tax obligations from vested equity award distribution.
- Filing date: June 11, 2026; intended sale date: June 11, 2026.
- Prior sales by Divita: 27,731 shares on March 11, 2026, and 19,132 shares on June 2, 2026.
Financial Impact
Sale of 18,074 shares valued at ~$125K, representing a small fraction of the company's $1.3B market cap.
Risk Factors
- Insider selling pattern: Divita has sold 64,937 shares total in the last three months, though all appear tied to equity vesting/tax obligations.
- Broader insider activity: 7 sells totaling $428K in the last 30 days, which could weigh on sentiment if interpreted as lack of confidence.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001959173-26-004564 |
| Document: 0001959173-26-004564-index.html | 0001959173-26-004564 |
| Document: 0001959173-26-004564.txt | 0001959173-26-004564 |
Track record
24 reports on TDOC
3 of 3 bullish or bearish reports moved the stock their way by T+1. Best: +2.52% at T+1 after the Oct 28, 2026 report. 3 of 3 went positive at some point.
Filters
- Nov 16, 2026today SC 13G Neutral 3/10 Entry $8.60 Now $8.70 +1.22% settles Nov 17
- Nov 6, 202610d ago 144 Neutral 3/10 Entry $8.77 to $8.98 Now $8.70 −0.80% ▲ +2.39% +0.03% vs SPY
- Nov 3, 202613d ago 3 / PRESS-RELEASE Neutral 2/10 Entry $9.70 to $9.41 Now $8.70 −10.31% ▼ −2.99% +1.42% vs SPY
- Nov 3, 202614d ago PTAB Trial Neutral 3/10 Entry $8.89 to $9.70 Now $8.70 −2.14% ▲ +9.11% +7.46% vs SPY
- Oct 28, 202619d ago Press Release Bearish 6/10 No price data
- Oct 28, 202619d ago 8-K Bearish 6/10 Entry $8.73 to $8.51 Now $8.70 +0.34% ▲ +2.52% +0.75% vs SPY
- Oct 28, 202620d ago PTAB Trial Neutral 3/10 Entry $8.73 to $8.51 Now $8.70 −0.34% ▼ −2.52% −0.75% vs SPY
- Oct 8, 20265w ago SC 13G Neutral 3/10 Entry $5.54 to $5.77 Now $8.70 +57.04% ▲ +4.15% +3.55% vs SPY
- Sep 25, 20267w ago 8-K Neutral 3/10 Entry $6.09 to $5.89 Now $8.70 +42.86% ▼ −3.28% −2.54% vs SPY
- Sep 11, 20269w ago 144 Neutral 2/10 Entry $6.16 to $6.50 Now $8.70 +41.23% ▲ +5.52% +5.97% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers